Todays Report: Today, State of Wisconsin Investment Board sells partial stakes of Amdocs Limited (DOX)

Today, State of Wisconsin Investment Board sells partial stakes of Amdocs Limited (DOX)

State of Wisconsin Investment Board decreased its stake in Amdocs Limited (NASDAQ:DOX) by 1.8% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 94,839 shares of the company’s stock after selling 1,700 shares during the period. State of Wisconsin Investment Board owned about 0.06% of Amdocs Limited worth $5,486,000 at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of the company. Royal Bank of Canada raised its stake in Amdocs Limited by 17.7% in the first quarter. Royal Bank of Canada now owns 238,074 shares of the company’s stock valued at $14,384,000 after buying an additional 35,745 shares during the last quarter. First Republic Investment Management Inc. increased its position in shares of Amdocs Limited by 121.0% in the first quarter. First Republic Investment Management Inc. now owns 9,017 shares of the company’s stock valued at $545,000 after buying an additional 4,937 shares in the last quarter. BNP Paribas Arbitrage SA increased its position in shares of Amdocs Limited by 0.6% in the second quarter. BNP Paribas Arbitrage SA now owns 29,796 shares of the company’s stock valued at $1,720,000 after buying an additional 184 shares in the last quarter. Capstone Asset Management Co. increased its position in shares of Amdocs Limited by 1.7% in the second quarter. Capstone Asset Management Co. now owns 45,779 shares of the company’s stock valued at $2,642,000 after buying an additional 749 shares in the last quarter. Finally, Denali Advisors LLC increased its position in shares of Amdocs Limited by 23.5% in the second quarter. Denali Advisors LLC now owns 124,500 shares of the company’s stock valued at $7,186,000 after buying an additional 23,700 shares in the last quarter. 88.17% of the stock is currently owned by institutional investors and hedge funds.

Amdocs Limited (NASDAQ:DOX) traded up 0.97% on Friday, hitting $60.13. 295,739 shares of the stock traded hands. Amdocs Limited has a 12 month low of $50.06 and a 12 month high of $61.33. The firm has a 50-day moving average price of $58.79 and a 200-day moving average price of $58.36. The company has a market capitalization of $8.86 billion, a PE ratio of 22.19 and a beta of 0.68.

Amdocs Limited (NASDAQ:DOX) last posted its earnings results on Tuesday, November 8th. The company reported $0.89 EPS for the quarter, beating analysts’ consensus estimates of $0.89 by $0.00. The business had revenue of $940.70 million for the quarter, compared to the consensus estimate of $941.19 million. Amdocs Limited had a net margin of 11.01% and a return on equity of 14.61%. The company’s revenue for the quarter was up 1.5% on a year-over-year basis. During the same quarter last year, the firm posted $0.84 EPS. Analysts forecast that Amdocs Limited will post $3.79 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 13th. Shareholders of record on Friday, December 30th will be given a dividend of $0.195 per share. This represents a $0.78 dividend on an annualized basis and a yield of 1.30%. Amdocs Limited’s dividend payout ratio (DPR) is 28.78%.

Several research analysts have recently issued reports on DOX shares. Oppenheimer Holdings Inc. reiterated an “outperform” rating and issued a $65.00 target price on shares of Amdocs Limited in a research note on Monday, August 8th. Jefferies Group upped their target price on shares of Amdocs Limited from $56.00 to $58.00 and gave the stock a “hold” rating in a research note on Tuesday, August 2nd. Finally, Bank of America Corp. reiterated a “buy” rating and issued a $63.00 target price on shares of Amdocs Limited in a research note on Wednesday, November 9th. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus price target of $63.33.

Amdocs Limited Company Profile

Related posts

Leave a Comment